http://orcid.org/0000-0001-9366-2211
References
- Pandya AG, Hynan LS, Bhore R, et al. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2011;64:78–83. e2.
- Handel A, Lima P, Tonolli V, et al. Risk factors for facial melasma in women: a case–control study. Br J Dermatol. 2014;171:588–594.
- Bagherani N, Gianfoldoni S, Smoller B. An overview on melasma. J Pigmentary Disord. 2015;2–10.
- Wang H-L, Avila G. Platelet rich plasma: myth or reality? Eur J Dent. 2007;1:192.
- Conde ME, Fernández SM, Suárez FR. Platelet-rich plasma: applications in dermatology. Actas Dermosifiliogr. 2015;106:104–111.
- Kim DH, Je YJ, Kim CD, et al. Can platelet-rich plasma be used for skin rejuvenation? Evaluation of effects of platelet-rich plasma on human dermal fibroblast. Annals Dermatol. 2011;23:424–431.
- Al-Shami SH. Treatment of periorbital hyperpigmentation using platelet-rich plasma injections. Am J Dermatol Venereol. 2014;3:87–94.
- Çayırlı M, Çalışkan E, Açıkgöz G, et al. Regression of melasma with platelet-rich plasma treatment. Annals Dermatol 2014;26:401–402.
- Ch Y, Ts R, Amini F. Response to intradermal autologous platelet rich plasma injection in refractory dermal melasma: report of two cases. J Health Transl Med. 2015;181–6.
- Singh A, Yadav S. Microneedling: advances and widening horizons. Indian Dermatol J. 2016;7:244.
- Sanchez NP, Pathak MA, Sato S, et al. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol. 1981;4:698–710.
- Hechtman KS, Uribe JW, Botto-vanDemden A, et al. Platelet-rich plasma injection reduces pain in patients with recalcitrant epicondylitis. Orthopedics. 2011;34:92.
- Arora S, Gupta B. Automated microneedling device–a new tool in dermatologist's kit–a review. J Pak Med Assoc. 2012;22:354–357.
- Budamakuntla L, Loganathan E, Suresh DH, et al. A randomised, open-label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling in patients with melasma. J Cutan Aesth Surg. 2013;6:139.
- Shin MK, Lee JH, Lee SJ, et al. Platelet‐rich plasma combined with fractional laser therapy for skin rejuvenation. Dermatol Surg. 2012;38:623–630.
- Kimbrough-Green CK, Griffiths CE, Finkel LJ, et al. Topical retinoic acid (tretinoin) for melasma in black patients: a vehicle-controlled clinical trial. Arch Dermatol. 1994;130:727–733.
- Wang X, Li Z, Zhang D, Li L, et al. A double-blind, placebo controlled clinical trial evaluating the efficacy and safety of a new skin whitening combination in patients with chloasma. J Cosmetics Dermatol Sci Appl. 2014;2014:92–98.
- Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg. 2005;31:1645–1650.
- MoubasherAE, Youssef EM, Abou-Taleb DA. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients. Dermatol Surg. 2014;40:874–882.
- Freitag F, Cestari T, Leopoldo L, et al. Effect of melasma on quality of life in a sample of women living in southern Brazil. J Eur Acad Dermatol Venereol. 2008;22:655–662.
- Passeron T. Melasma pathogenesis and influencing factors–an overview of the latest research. J Eur Acad Dermatol Venereol. 2013;27:5–6.
- Rutkowski JL, Thomas JM, Bering CL, et al. An analysis of a rapid, simple, and inexpensive technique used to obtain platelet-rich plasma for use in clinical practice. J Oral Implantol. 2008;34:25–33.
- Javaheri SM, Handa S, Kaur I, et al. Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Int J Dermatol. 2001;40:354–357.
- De La Mata J. Platelet rich plasma. A new treatment tool for the rheumatologist? Reumatol Clin. 2013;9:166–171.
- Yun WJ, Bang SH, Min KH, et al. Epidermal growth factor and epidermal growth factor signaling attenuate laser‐induced melanogenesis. Dermatol Surg. 2013;39:1903–1911.